Combination gene therapy of IL-12 and allogeneic MHC class I gene via stimulating NK cytolytic activity

Anticancer Research

Volumn 19, Issue 5 B, 1999, Pages 4337-4342

  Yoon, Seong Jun ^b   Heo, Dae Seog ^a,b   Kang, Jung O K ^b   Kim, Noe Kyeong ^b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Allogeneic MHC class I; Gene therapy; IL 12; Neoplasm; NK activity

Indexed keywords

INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENICITY; CELL INFILTRATION; CELL STIMULATION; CONTROLLED STUDY; CYTOLYSIS; EFFECTOR CELL; FEMALE; GENE EXPRESSION; GENE THERAPY; HISTOLOGY; INFLAMMATION; MOUSE; NATURAL KILLER CELL; NECROSIS; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH;

EID: 0032779139     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Anderson FW: Gene therapy for cancer. Hum Gene Ther 5: 110-116, 1994.
2. Webber JS and Rosenberg SA: Modulation of murine tumor major histocompatibility antigen by cytokines in vivo and in vitro. Cancer Res 48: 5818-5824, 1988.
3. Varesio L, Blasi E, Thurman GB, Talmadge JE, Wiltrout RE and Herberman RB: Potent activation of mouse macrophages by recombinant interferon-γ. Cancer Res 44: 4465-4469, 1984.
4. Armstrong CA, Botella R, Galloway TH, Murray N, Kramp JM, Song IS and Ansel JC: Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells. Cancer Res 56: 2191-2198, 1996.
5. Fearon E, Pardoll D, Itaya T, Golumbek P, Levitsky HI, Simons JW, Karasuyama H, Vogelstein B and Frost P: Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60: 397-403, 1990.
6. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF and Gately MK: Antitumor and anti-metastatic activity of interleukin-12 against murine tumors. J Exp Med 178: 1223-1230, 1993.
7. Wolf SF, Temple PA, Kokayashi M, Young D., Dicig M, Lowe L and Dzialo R: Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 146: 3074-3081, 1990.
8. Kubin M, Kamoun M and Trinchieri G: Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med 180: 11-222, 1994.
9. Azzoni L, Kanakaraj P, Zatsepina O and Pcrussia B: IL-12-induced activation of NK and T cells occurs in the absence of immediate-early activation gene expression. J Immunol 157: 3235-3241, 1996.
10. Wolff, JA, Malone RW, Williams P, Fitz L, Ferenz C and Hewick RM: Direct gene transfer into mouse muscle in vivo. Science 247: 1465-1468, 1990.
11. Nabel GJ, Yang ZY and Nabel EG: Direct gene transfer for treatment of human cancer. Ann NY Acad Sci 772: 227-231, 1995.
12. Hui KM, Sim T, Foo TT and Oei AA: Tumor rejection mediated by transfection with allogeneic class I major histocompatibility gene. J Immunol 143: 3835-3843, 1989.
13. Li M-F, Muller J, Xu F, Hearing VJ and Gorelik E: Inhibition of melanoma-associated antigen expression and ecotropic retrovirus with major histocompatibility complex class I gene. Cancer Res 56: 4464-4474, 1996.
14. Sambrook J, Fritsh EF and Maniatis T: Molecular cloning (2nd ed.) 7.1-7.81, New York, Cold spring harbor laboratory press, 1989.
15. Yoon SJ, Heo DS, Kang JO, Lee SG, Kim CD, Sung MW and Kim NK: Synergistic anti-tumor effects with co-expression of GM-CSF and IFN-γ in murine tumors. Int J Cancer 77: 907-912, 1998.
16. Schoenhaut DS, Chua AO, Wolitzky AG, Quinn PM, Dwyer CM, McComas W, Familltti PC, Gately MK and Gubler U: Cloning and expression of murine IL-12. J Immunol 148: 3433-3440, 1992.
17. Weiss E, Golden L and Zakut R: The DNA sequence of the H-2Kb gene: Evidence for gene conversion as a mechanism for the generation of polymorphism in histocompatibility antigens. EMBO J 2: 453-462, 1983.
18. Cole GA, Clements V, Carcia E and Ostrand-Rosenberg S: Allogeneic H-2 antigen expression is insufficient for tumor rejection. Proc Natl Acad Sci USA, 84: 8613-8617, 1987.
19. Nabel GJ, Nabel EG, Yang ZY, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gorden D and Chang AE: Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA, 90: 11307-11311, 1993.
20. Trinchieri G: IL-12- a proinflammatory cytokine with immunomodulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13: 251-276, 1995.
21. Fraser CC, Sykes M, Lee RS, Sachs DH, LeGuerin C: Specific unresponsiveness to a retrovirally-transferred class I antigen into controlled through the helper pathway. J Immunol 154: 1587-1595, 1995.
22. Plautz GE, Yang ZY, Wu BY, Gao X, Huang L and Nabel GJ: Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc Natl Acad Sci USA 90: 4645-4649, 1993.
23. Chan SH, Kobayashi M, Santoli D, Perussia B and Trinchieri G: Mechanisms of IFN-γ induction by natural killer cell stimulatory factor (NKSF/IL-12). J Immunol 148: 92-98, 1992.
24. Chehimi J, Starr S, Frank M, Rengaraju M, Jackson SJ, Lanes C, Kobayashi M, Perussia B, Young D and Nickbarg E: Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med 175: 789-794, 1992.